FCB Health Network president & CEO Dana Maiman today announced Jill Lesiak has joined Mosaic Group – the Network’s full-service payer and market access healthcare agency – as executive creative director. Lesiak will report to FCB Health New York chief creative officer Kathleen Nanda and oversee creative strategy across all clients and brands, helping Mosaic Group’s clients achieve their access and reimbursement goals.
With more than 20 years of experience in the market access space, Lesiak has spent the majority of her career supporting patient access. She also has healthcare marketing experience outside of the agency world, after holding previous positions with Express Scripts (formerly Merck-Medco) and Prudential Healthcare. Most recently, Lesiak served as agency co-lead and creative director for Ogilvy Health’s market access group.
With patient access to lifesaving treatments perhaps more top-of-mind than ever before, FCB Health Network continues to prioritize best-in-class talent to serve its clients and their patients.
“We needed someone with deep payer experience, but also a brilliant strategic mind and tremendous creative talent,” Maiman said. “Jill is the perfect fit, as we know she will meet and exceed the same high creative standards we set for the rest of the FCB Health Network.”
Working on the healthcare and pharmacy benefit managers sides infused Lesiak with the need to help ensure that patients gain access to the therapies they most need, and this passion carried on into her agency career. Lesiak replaces Denise Lenci, who, after six years with FCB Health Network, is retiring and will move into a consultancy role in which she’ll continue to share her payer and market access expertise with the agency and its clients. Lesiak’s and Lenci’s approaches to market access are founded on similar standards of excellence, forged from multiple years of working together in the industry.
“I’m extremely excited to lead the creative team at Mosaic, and I plan to continue Denise’s legacy of bringing innovative communications to market access,” Lesiak said. “Market access is core to the success of our clients’ brands, and we are at the forefront of merging creativity and strategy in this space so that we can continue to ensure patient access to life-changing therapies.”